Case | HBS Case Collection | February 2006 (Revised July 2007)

Corporate Venture Capital at Eli Lilly

by Richard G. Hamermesh, Ron Laufer and David Lane

Abstract

Reviews the role of corporate venture capital and its history at Eli Lilly. Also presents a challenging venture investment opportunity.

Keywords: Venture Capital; Investment; Pharmaceutical Industry;

Citation:

Hamermesh, Richard G., Ron Laufer, and David Lane. "Corporate Venture Capital at Eli Lilly." Harvard Business School Case 806-092, February 2006. (Revised July 2007.)